| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.02 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |